CD34 and diabetes mellitus: By leveraging an in vitro DM model based on cord-blood derived CD34+ HSPCs, in the present study we provide pre-clinical evidence that HG exposure per se is sufficient to epigenetically promote a senescent and pro-inflammatory phenotype, resembling SASP.